Acorda Therapeutics Inc Vermögensrendite
Was ist das Vermögensrendite von Acorda Therapeutics Inc?
Vermögensrendite von Acorda Therapeutics Inc ist -83.28%
Was ist die Definition von Vermögensrendite?
Die Vermögensrendite gibt an, wie rentabel die Vermögenswerte eines Unternehmens bei der Erzielung von Einnahmen sind. Sie wird berechnet, indem das Nettoeinkommen durch die durchschnittliche Bilanzsumme geteilt wird.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Vermögensrendite von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit vermögensrendite ähnlich Acorda Therapeutics Inc
- C-Bond Systems hat Vermögensrendite von -83.61%
- Obalon Therapeutics Inc hat Vermögensrendite von -83.58%
- MCI Onehealth Technologies hat Vermögensrendite von -83.54%
- Ortho Regenerative Technologies hat Vermögensrendite von -83.35%
- Advicenne SA hat Vermögensrendite von -83.33%
- Cantex Mine Development hat Vermögensrendite von -83.29%
- Acorda Therapeutics Inc hat Vermögensrendite von -83.28%
- Dotz Nano hat Vermögensrendite von -83.20%
- Courbet Sa hat Vermögensrendite von -83.07%
- Canadian Orebodies hat Vermögensrendite von -83.05%
- NxGold hat Vermögensrendite von -83.04%
- China Environmental Technology hat Vermögensrendite von -82.87%
- Cue Biopharma Inc hat Vermögensrendite von -82.85%